These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 33245352)

  • 21. MEDICINE. Global control of hepatitis C virus.
    Cox AL
    Science; 2015 Aug; 349(6250):790-1. PubMed ID: 26293940
    [No Abstract]   [Full Text] [Related]  

  • 22. Measuring hepatitis C virus elimination as a public health threat: Beyond global targets.
    van Santen DK; Sacks-Davis R; Doyle JS; Scott N; Prins M; Hellard M
    J Viral Hepat; 2020 Aug; 27(8):770-773. PubMed ID: 32187431
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elimination of Hepatitis C Virus in Australia: Laying the Foundation.
    Dore GJ; Hajarizadeh B
    Infect Dis Clin North Am; 2018 Jun; 32(2):269-279. PubMed ID: 29778255
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The obstacle is the way: Finding a path to hepatitis C elimination.
    Lo Re V; Price JC; Schmitt S; Terrault N; Bhattacharya D; Aronsohn A
    Hepatology; 2024 Jul; 80(1):3-7. PubMed ID: 38752360
    [No Abstract]   [Full Text] [Related]  

  • 25. A model of the economic benefits of global hepatitis C elimination: an investment case.
    Scott N; Kuschel C; Pedrana A; Schroeder S; Howell J; Thompson A; Wilson DP; Hellard M
    Lancet Gastroenterol Hepatol; 2020 Oct; 5(10):940-947. PubMed ID: 32730785
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Leaving no one behind: Towards equitable global elimination of hepatitis C.
    Dahl EH; Zahid H; Aslam K; Jafri W
    J Glob Health; 2020 Jun; 10(1):010308. PubMed ID: 32257136
    [No Abstract]   [Full Text] [Related]  

  • 27. Public Health Approaches Toward Eliminating Hepatitis C Virus in Rhode Island.
    Murphy M; Howe K; Marak T; Bertrand T; Maynard M; Ndoye CD; Joseph R; Fingerut J; Chan PA
    R I Med J (2013); 2020 Jun; 103(5):22-25. PubMed ID: 32481775
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Progress Toward Hepatitis B and Hepatitis C Elimination Using a Catalytic Funding Model - Tashkent, Uzbekistan, December 6, 2019-March 15, 2020.
    Dunn R; Musabaev E; Razavi H; Sadirova S; Bakieva S; Razavi-Shearer K; Brigida K; Kamili S; Averhoff F; Nasrullah M
    MMWR Morb Mortal Wkly Rep; 2020 Aug; 69(34):1161-1165. PubMed ID: 32853186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Eradicating hepatitis C virus: The APRN's role.
    Pozza R; McCoy-Hill C; Hall K; Hefner A; Wilgers K; Tapelband J; Masroor M; Hassanein T
    Nurse Pract; 2019 Nov; 44(11):16-27. PubMed ID: 31567700
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Can hepatitis C be eradicated in the United States?
    Edlin BR; Winkelstein ER
    Antiviral Res; 2014 Oct; 110():79-93. PubMed ID: 25110202
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis C: The beginning of the end-key elements for successful European and national strategies to eliminate HCV in Europe.
    Papatheodoridis GV; Hatzakis A; Cholongitas E; Baptista-Leite R; Baskozos I; Chhatwal J; Colombo M; Cortez-Pinto H; Craxi A; Goldberg D; Gore C; Kautz A; Lazarus JV; Mendão L; Peck-Radosavljevic M; Razavi H; Schatz E; Tözün N; van Damme P; Wedemeyer H; Yazdanpanah Y; Zuure F; Manns MP
    J Viral Hepat; 2018 Mar; 25 Suppl 1():6-17. PubMed ID: 29508946
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Excellence in viral hepatitis elimination - Lessons from Georgia.
    Averhoff F; Lazarus JV; Sergeenko D; Colombo M; Gamkrelidze A; Tsertsvadze T; Butsashvili M; Metreveli D; Sharvadze L; Hellard M; Gnes S; Gabunia T; Nasrullah M
    J Hepatol; 2019 Oct; 71(4):645-647. PubMed ID: 31356831
    [No Abstract]   [Full Text] [Related]  

  • 33. Eradication of hepatitis C infection: the importance of targeting people who inject drugs.
    Hellard M; Doyle JS; Sacks-Davis R; Thompson AJ; McBryde E
    Hepatology; 2014 Feb; 59(2):366-9. PubMed ID: 23873507
    [No Abstract]   [Full Text] [Related]  

  • 34. Identifying the lower age limit for hepatitis C screening in large elimination programmes in highly endemic areas.
    Hamid S; Abid A; Dore GJ
    Lancet Gastroenterol Hepatol; 2021 Feb; 6(2):89-90. PubMed ID: 33444535
    [No Abstract]   [Full Text] [Related]  

  • 35. Elimination on the agenda for hepatitis C.
    Burki T
    Lancet Infect Dis; 2014 Jun; 14(6):452-3. PubMed ID: 24971446
    [No Abstract]   [Full Text] [Related]  

  • 36. Elimination of hepatitis C in Europe: can WHO targets be achieved?
    Matičič M; Lombardi A; Mondelli MU; Colombo M;
    Clin Microbiol Infect; 2020 Jul; 26(7):818-823. PubMed ID: 31978546
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Investment cases for hepatitis C: never more important.
    Wingrove C; Hicks J; Regan S; Wang S
    Lancet Gastroenterol Hepatol; 2021 May; 6(5):340-341. PubMed ID: 33857440
    [No Abstract]   [Full Text] [Related]  

  • 38. Hepatitis C Virus Diagnosis and the Holy Grail.
    Applegate TL; Fajardo E; Sacks JA
    Infect Dis Clin North Am; 2018 Jun; 32(2):425-445. PubMed ID: 29778264
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatitis C: Is eradication possible?
    Lombardi A; Mondelli MU;
    Liver Int; 2019 Mar; 39(3):416-426. PubMed ID: 30472772
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Five Questions Concerning Managing Hepatitis C in the Justice System: Finding Practical Solutions for Hepatitis C Virus Elimination.
    Spaulding AC; Adee MG; Lawrence RT; Chhatwal J; von Oehsen W
    Infect Dis Clin North Am; 2018 Jun; 32(2):323-345. PubMed ID: 29778259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.